Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Myriad Genetics (MYGN) Tax Provisions (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Tax Provisions for 17 consecutive years, with -$1.0 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions fell 129.41% to -$1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$29.2 million through Dec 2025, down 848.72% year-over-year, with the annual reading at -$29.2 million for FY2025, 868.42% down from the prior year.
  • Tax Provisions for Q4 2025 was -$1.0 million at Myriad Genetics, down from $1.2 million in the prior quarter.
  • The five-year high for Tax Provisions was $15.2 million in Q3 2021, with the low at -$35.9 million in Q4 2021.
  • Average Tax Provisions over 5 years is -$4.4 million, with a median of -$500000.0 recorded in 2024.
  • The sharpest move saw Tax Provisions surged 800.0% in 2024, then crashed 29400.0% in 2025.
  • Over 5 years, Tax Provisions stood at -$35.9 million in 2021, then skyrocketed by 72.7% to -$9.8 million in 2022, then soared by 88.78% to -$1.1 million in 2023, then surged by 409.09% to $3.4 million in 2024, then crashed by 129.41% to -$1.0 million in 2025.
  • According to Business Quant data, Tax Provisions over the past three periods came in at -$1.0 million, $1.2 million, and -$100000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.